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Introduction: Risk of testicular germ cell tumors (TGCT) is consistently associated with a
history of cryptorchidism (CO) in epidemiologic studies. Factors modifying the association
may provide insights regarding etiology of TGCT and suggest a basis for individualized care
of CO. To identify modifiers of the CO-TGCT association, we conducted a comprehensive,
quantitative evaluation of epidemiologic data.
Materials and Methods: Human studies cited in PubMed or ISI Web of Science indices
through December 2011 and selected unpublished epidemiologic data were reviewed
to identify 35 articles and one unpublished dataset with high-quality data on the CO-
TGCT association. Association data were extracted as point and 95% confidence interval
estimates of odds ratio (OR) or standardized incidence ratio (SIR), or as tabulated data.
Values were recorded for each study population, and for subgroups defined by features of
study design, CO and TGCT. Extracted data were used to estimate summary risk ratios
(sRR) and evaluate heterogeneity of the CO-TGCT association between subgroups.
Results: The overall meta-analysis showed that history of CO is associated with four-
fold increased TGCT risk [RR = 4.1(95% CI = 3.6–4.7)]. Subgroup analyses identified
five determinants of stronger association: bilateral CO, unilateral CO ipsilateral to TGCT,
delayed CO treatment, TGCT diagnosed before 1970, and seminoma histology.
Conclusions: Modifying factors may provide insight into TGCT etiology and suggest
improved approaches to managing CO. Based on available data, CO patients and their
parents or caregivers should be made aware of elevated TGCT risk following orchidopexy,
regardless of age at repair, unilateral vs. bilateral non-descent, or position of undescended
testes.
Keywords: testicular neoplasms, cryptorchidism, seminoma, non-seminoma, meta-analysis
INTRODUCTION
Cryptorchidism (CO), or undescended testis, affects approxi-
mately 3% of all male live births, making it one of the most
common congenital disorders. Despite a high rate of spontaneous
resolution during the first year of life, CO is firmly established
as the primary risk factor for subsequent development of tes-
ticular germ cell tumors (TCGT) (John Radcliffe Hospital Study
Group, 1992; Berkowitz et al., 1993; Thong et al., 1998; Paulozzi,
1999). TGCT are the most common form of malignancy among
young men in the United States. Advances in systemic therapy
have improved overall TGCT survival from 83% in 1975–1979
to 96% in 1999–2005 (Jemal et al., 2010). However, incidence
of TGCT has nearly doubled during the same time period (Fast
Stats), and it is now evident that significant sequelae include
subfertility, (Walsh et al., 2009) sexual dysfunction, (Magelssen
et al., 2006) and elevated risk of second malignancy (Moller et al.,
1993; Fossa et al., 2005; Travis et al., 2005; Van den Belt-Dusebout
et al., 2007). Therefore, a clear understanding of etiologic risk fac-
tors and more comprehensive risk stratification is a priority of
TGCT research.
Risk of CO and TGCT are associated with additional disor-
ders of the male reproductive system, hypospadias, and impaired
spermatogenesis. This pattern is postulated to reflect origins of
all of these conditions in errors of development of the fetal testis
according to the testicular dysgenesis syndrome hypothesis, which
elegantly accounts for experimental research identifying genetic
and early environmental factors predisposing to these phenotypes
in animal models (Skakkebæk et al., 2001). Little is currently
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known regarding the specific insults that may lead to elevated
risk of individual and joint phenotypes in humans, or the stages
of testicular development when such factors may act. In the
present report we comprehensively reviewed the rich set of pub-
lished observational data on co-occurrence of CO and TGCT as a
first step in disentangling the complex associations among these
related conditions.
Currently, little is known about the overall characterization of
tumor risk in patients with a prior history of CO. Individual esti-
mates of relative risk from the literature range from 1.35 (95%
CI = 0.73–2.48) to 18 (95% CI = 12–26), (Miller and Seljelik,
1971; Mostofi, 1973; Morrison, 1976; Henderson et al., 1979;
Loughlin et al., 1980; Schottenfeld et al., 1980; Wobbes et al.,
1980; Fonger et al., 1981; Coldman et al., 1982; Depue et al.,
1983; Mills et al., 1984; Pottern et al., 1985; Moss et al., 1986;
Giwercman et al., 1987; Swerdlow et al., 1987, 1997; Gershman
and Stolley, 1988; Strader et al., 1988; Thornhill et al., 1988;
Haughey et al., 1989; Benson et al., 1991; Stone et al., 1991;
United Kingdom Testicular Cancer Study Group (UK), 1994;
Gallagher et al., 1995; Davies et al., 1996; Moller et al., 1996;
Prener et al., 1996; Petridou et al., 1997; Sabroe and Olsen, 1998;
Sigurdson et al., 1999; Weir et al., 2000; Stang et al., 2001; Bonner
et al., 2002; Herrinton et al., 2003; Dieckmann and Pichlmeier,
2004; Kanto et al., 2004; Hardell et al., 2007; McGlynn et al.,
2007; Myrup et al., 2007; Pettersson et al., 2007; Walschaerts
et al., 2007; Dusek et al., 2008) suggesting significant differences
in study design and/or heterogeneity of the effects of clinical
characteristics which may impact risk of TGCT amongst males
with CO. Potential modifying factors include anatomic location
(abdominal vs. inguinal vs. ectopic) and laterality (unilateral vs.
bilateral) of undescended testes, age at treatment, mode of treat-
ment (spontaneous descent vs. hormones or orchiopexy), as well
as temporal trends in TGCT risk, and tumor histology. Previous
meta-analyses evaluating the CO-TGCT association have been
limited to specific subsets of these factors (Castejon Casado et al.,
2000; Walsh et al., 2007; Tuazon et al., 2008; Akre et al., 2009).
We report a broader systematic review and meta-analysis of the
overall association between CO-TGCT, and explore the possible
impact of study design, temporal trends, and clinical features on
this association.
MATERIALS AND METHODS
The analysis followed specifications for meta-analysis of observa-
tional studies in epidemiology (Stroup et al., 2000) and adhere
to PRISMA guidelines (Moher et al., 2009). The outcome was
TGCT. The exposure was CO, defined as a testicle undescended
at birth that subsequently descended spontaneously, was reposi-
tioned into the scrotum by orchiopexy or hormone therapy, or
remained undescended. Subgroups were defined by features of
study design, CO, and TGCT.
STUDY SELECTION
We searched the MEDLINE (National Library of Medicine,
Bethesda, MD, USA) Pubmed interface without language restric-
tions for human studies published through December 2011,
using key words “CO,” “undescended testicle,” “undescended
testis,” “undescended testes,” “case-control study,” “cohort study”
in combination with “testicular cancer,” “testicular carcinoma,”
“testicular neoplasia,” “testis cancer,” “testis carcinoma,” “testis
neoplasia,” reviewing also reports cited in retrieved articles and
review articles, and by citation indices (ISI Web of Science) for
these reports. We also sought high-quality unpublished data. The
Review Protocol has not been registered.
DATA EXTRACTION AND CODING
A genetic counselor and a statistician reviewed retrieved articles
to determine eligibility for the meta-analysis, resolving conflicts
by consensus among themselves and an epidemiologist. Data
on study design, overall CO-TGCT associations, and subgroup-
specific CO-TGCT associations were extracted systematically by
a single reviewer and confirmed by two others. We eliminated
redundant data arising from repeated publication, consulting
original authors whenever possible.
We extracted published information on RRs relating CO to
TGCT as follows: when provided, we recorded point estimates
of the odds ratio (OR) for case-control studies and standard-
ized incidence ratio (SIR) for cohort studies, with corresponding
standard error or information from which it could be calcu-
lated (variance, CI, p-value). When only a point estimate was
reported, we requested corresponding variance term from orig-
inal authors. If the OR estimate was not provided, we calculated
it from published tabular data.
Features of study design
We noted the following features of each study: data structure
(case-control study of TGCT, cohort study of males born with
CO, TGCT cases for whom frequency of CO was compared
to external population), country where study was conducted,
race/ethnicity of participants, and source of CO data (birth
record, medical record before TGCT diagnosis, medical record
at/following TGCT diagnosis, reported by participant and/or his
mother). For case-control and cohort studies we noted source of
reference group (population or population-based registry, hos-
pital or neighborhood, friend). We distinguished published RR
estimates extracted from those we calculated from published data;
for published estimates, we tabulated covariates and matching
variables in original analyses.
Features of cryptorchidism
When possible we extracted or calculated RR estimates of CO-
TGCT association for subgroups defined by each of several fea-
tures of CO: laterality of undescended testicle relative to TGCT
(unilateral CO contralateral to tumor, unilateral CO with rela-
tion to tumor unspecified, unilateral CO ipsilateral to tumor,
bilateral CO), level of maldescent (ectopic, inguinal, abdomi-
nal), whether definition of CO included spontaneous descent,
means of resolving CO (spontaneous, orchiopexy or hormone
therapy, remained undescended), and age at resolution. For this
variable we used frequently published categories (0–9 years of
age, 10–14 years, 10 years or older, 15 years or older) (United
Kingdom Testicular Cancer Study Group (UK), 1994; Moller
et al., 1996; Swerdlow et al., 1997) combining data from smaller
intervals if provided (Swerdlow et al., 1997). Among studies
with alternate cut points, one provided raw data from which
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we recalculated estimates within above strata (Herrinton et al.,
2003); for four others (Pottern et al., 1985; Strader et al., 1988;
Myrup et al., 2007; Pettersson et al., 2007) we assigned data
to closest category corresponding to above strata (Table S3,
footnotes b–d).
Features of testicular germ cell tumors
We extracted or calculated RR estimates for subgroups defined
by histology (non-seminoma, non-seminoma/mixed germ cell
tumor (GCT), mixed GCT, seminoma). A separate code formixed
GCT was introduced in 1990 (ICD-0-2), and tumors of mixed
histology were previously coded as non-seminoma. Therefore, for
studies including diagnoses before 1990, if authors did not specify
that non-seminoma excluded mixed histology, we coded reported
non-seminoma as “non-seminoma/mixed GCT.” As a measure of
year of TGCT diagnosis, we determined midpoint of range of
years of diagnosis among cases participating in each study.
Unpublished data
Original population-based case-control data (Lacson et al.,
2012) were provided before publication. Briefly, 163 TGCT
cases identified by the Los Angeles County Cancer Surveillance
Program (CSP) and 284 age-matched neighborhood controls
were enrolled. TGCT data (histologic type, laterality, age at diag-
nosis) were provided by the CSP, and CO data (laterality, age at
resolution, mean of resolution) were provided by participants and
their mothers during in-person interviews.
STATISTICAL ANALYSES
Estimating overall and stratum-specific summary RR of CO-TGCT
association
We conducted all meta-analyses using a random effects model,
which accounts for between- and within-study variance thereby
incorporating the conservative assumption that individual stud-
ies estimate different effect sizes (Sutton et al., 2000). We used
STATA 8.0 (Stata Corp, College Station, TX) to weight natural
log of each contributing OR or SIR estimate by the reciprocal
of the corresponding variance. We used this technique to esti-
mate overall and stratum-specific summary relative risk (sRR)
estimates. Forest plots were graphed displaying each study’s
contribution to sRRs.
Meta-analyses were performed separately for case-control
(Tables S2–S4, columns A) and cohort (Tables S2–S4, columns
B) studies, with summary measures subsequently pooled.
Resulting sRR estimates [Figures 1A, 2A–C and 3A–C;
Tables S2–S4, columns C (boldface)] summarize available
data on CO-TGCT associations from studies with reference
groups judged comparable to cases. Other articles compared CO
prevalence of TGCT cases with CO prevalence from external
FIGURE 1 | Forest and funnel plots for overall association of
testicular germ cell tumor (TGCT) risk with history of
cryptorchidism (A) Forest plot for combined cohort and case-control
data; (B) Funnel plot for combined cohort and case-control data;
(C) Forest plot for TGCT case series data; (D) Funnel plot for TGCT
case series data.
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FIGURE 2 | Forest plots of relative risk estimates relating cryptorchidism to risk of TGCT, stratified by features of cryptorchidism; (A) By laterality of
cryptorchidism relative to tumor; (B) By method whereby cryptorchidism was resolved; (C) By age at treatment for cryptorchidism.
populations, rather than source population of the cases; limited
comparability in such studies is now recognized as a potential
source of severe bias (Rothman et al., 2008). We therefore
summarized these data separately (Figure 1C; Tables S2–S4,
column D).
We implemented Egger’s test of publication bias, assessed het-
erogeneity by appropriate p-value and I2 (Berkowitz et al., 1993)
estimates, and assessed trends as described in Appendix Methods,
along with procedures for imputation and sensitivity analysis.
ROLE OF THE FUNDING SOURCE
Sponsors had no role in the design, implementation, or reporting
of the research. Drs. Victoria K. Cortessis and Leslie Bernstein had
full access to all of the original data in the study and take respon-
sibility for the integrity of the data and the accuracy of the data
analysis.
RESULTS
We identified 147 published articles reporting on both CO
and TGCT in humans, eliminating those that did not pro-
vide data relating CO to TGCT risk (N = 95, not cited), or
were duplicate reports of data included in the analysis (10
reports, Table S1). Data from 35 of the remaining 42 reports
and raw data from one unpublished case-control study con-
tributed to meta-analyses on which we base our inferences
(Table 1A; Figure S1). We requested from authors of three of
these reports (Moss et al., 1986; Strader et al., 1988; Swerdlow
et al., 1987) standard error data corresponding to published his-
tology stratum-specific point estimates, and received these for
one (Strader et al., 1988). In all, data on 9542 TGCT cases
contributed to the analyses. For historical interest, we sepa-
rately summarized estimates from the remaining seven reports,
whose authors compared CO among TGCT case-series with
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FIGURE 3 | Forest plots of relative risk estimates relating
cryptorchidism to risk of TGCT, stratified by features of TGCT;
(A) By histologic type of tumor; (B) By year of TGCT diagnosis
(midpoint for study); (C) By histologic type of tumor and year of
TGCT diagnosis (midpoint for study). 1Mixed; 2Non-Seminoma;
3Non-seminoma+Mixed.
frequencies of CO measured outside source populations of the
cases (Table 1B).
Sensitivity analyses revealed that no single case-control or
cohort study influenced either overall or stratum-specific esti-
mates of RR sufficiently to alter interpretation (results not
shown). Egger’s tests revealed no evidence of publication bias
among cohort data (p = 0.68), case-control data (p = 0.34), or
these data types combined (p = 0.40); however, addition of data
from the TGCT case series introduced an impression of substan-
tial publication bias (p = 0.01). Visual inspection of Begg’s funnel
plots showed that while magnitude and standard error of RR esti-
mates from most cohort and case-control studies (34 of 36) are
within the 95% confidence limits (Figure 1B), this is true of a far
smaller proportion of TGCT case-series (4 of 7, Figure 1D).
OVERALL CO-TGCT ASSOCIATION AND EFFECTS OF STUDY DESIGN
We estimated sRR of developing TGCT following a history
of CO to be 4.0(95% CI = 3.4–4.6) in case-control stud-
ies (Table S2Ai) and 4.8(95% CI = 3.2–7.2) in cohort studies
(Table S2Bi). The sRR estimated by pooling these results was
4.1(95% CI = 3.6–4.7), with 14% of the variance (I2) attributed
to between-study heterogeneity (Figures 1A,B; Table S2Ci). By
contrast, sRR estimated from studies that compared CO fre-
quencies between TGCT case series and external populations was
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14.8(95% CI = 10.7–20.4), with 86% of variance attributed to
between-study heterogeneity (Figures 1C,D; Table S2Di).
Two additional features of study design appeared to mod-
ify sRR estimated among case-control and cohort studies: time
CO was recorded, and inclusion of spontaneous descent in CO
definition. The RR estimate was notably greater, 9.9(95% CI =
3.5–28.2), in the single study (Mills et al., 1984) that deter-
mined CO history from medical record entries made around
the time of TGCT diagnosis, and substantially lower, 1.3(95%
CI = 0.7–2.5), in the single study (Sabroe and Olsen, 1998) in
which CO had been recorded at birth. This latter study was likely
the only one to have included in the CO group a large pro-
portion of men whose testes would have descended in the first
months of life. The same study appeared to be largely responsible
for modification by whether definition of CO included sponta-
neous descent (pheterogeneity = 0.002 for analysis including this
study, pheterogeneity = 0.57 for analysis excluding it, Table S2Cvi).
Accordingly, this study was a clear outlier in the funnel plot
(Figure 1B), while all others fell very near or within the 95%
confidence limits.
MODIFICATION BY FEATURES OF CRYPTORCHIDISM
Several features of CO appeared to modify the CO-TGCT asso-
ciation (Figure 2; Table S3). Analyses stratified on laterality of
undescended testes relative to TGCT revealed an apparent trend:
sRR estimates increased steadily in progression from TGCT aris-
ing in testes contralateral to unilateral CO [sRR = 1.5(95%
CI = 0.9–2.6)], on unspecified side relative to unilateral CO
[sRR = 3.5(95% CI = 2.7–4.7)], ipsilateral to unilateral CO
[sRR = 5.4(95% CI = 3.7–7.8)], and in either testis follow-
ing bilateral CO [sRR = 9.8(95% CI = 6.2–15.7)] (Figure 2A;
Table S3Ci). Data on anatomic location of undescended testes,
provided for no case-control study and only one cohort study
(Swerdlow et al., 1997), were insufficient to determine whether
TGCT risk differs appreciably following abdominal vs. inguinal
non-descent (Table S3Cii). Therefore, the meta-analysis did not
confirm the report from a single TGCT case series (Stone
et al., 1991) of far higher RR following abdominal non-descent
(Table S3Dii).
In analyses stratified on means of resolving CO, estimates
increased in the progression of testes that descended sponta-
neously [sRR = 1.3(95% CI = 0.9–1.8)], testes repositioned by
surgery or hormone therapy [sRR= 4.7(95%CI = 3.7–6.1)], and
testes remaining undescended [sRR = 6.2(95% CI = 3.7–10.4)]
(Figure 2B; Table S3Ciii). Analyses stratified on both means of
resolution and age at resolution suggested greater RR among
those with older age at spontaneous descent or therapeutic resolu-
tion, although estimates for those who experienced spontaneous
descent did not achieve statistical significance (Figure 2C and
Table S3Civ).
MODIFICATION BY FEATURES OF TGCT
Analyses relating CO to tumor histology were conducted first
in a subset of data excluding three studies that reported “no
difference” in RR of seminoma vs. non-seminoma without pro-
viding stratum-specific estimates. The results hinted that RR
of seminoma may exceed that of non-seminoma (Table S4Ci).
To minimize the possibility that systematic omission of data
from studies reporting no difference had spuriously created this
impression, we repeated this analysis using a fuller set of data that
included values imputed for those studies; these results also sug-
gested a stronger association of CO with seminoma (Figure 3A;
Table S4Cii).
Analyses within strata defined by year of TGCT diag-
nosis suggest that magnitude of the CO-TGCT association
diminished steadily from the 1950’s forward. Highest sRR,
6.8(95% CI = 4.2–10.9), was estimated among studies with
midpoint year of TGCT diagnosis in the 1950’s, and lowest,
3.6(95% CI = 3.1–4.1), in studies with midpoint 1990 or later
(ptrend < 0.001; Figure 3B; Table S4Ciii). Further stratification
on histology, possible only for 1960’s forward, revealed that this
decrease results largely from a dramatic decrease in the CO-
seminoma association [sRR= 9.3(95% CI = 4.0–21.8) for 1960–
1969, sRR = 3.4(95% CI = 2.5–4.5) for 1990+; ptrend = 0.009),
in contrast to no clear trend for other histologies (ptrend = 0.320)
(Figure 3C; Table S4Civ).
TRENDS IN OCCURRENCE OF INDIVIDUAL CONDITIONS
Analyses of frequency of CO among controls participating in the
case-control studies, (Morrison, 1976; Henderson et al., 1979;
Loughlin et al., 1980; Schottenfeld et al., 1980; Coldman et al.,
1982; Depue et al., 1983; Mills et al., 1984; Pottern et al., 1985;
Moss et al., 1986; Swerdlow et al., 1987; Gershman and Stolley,
1988; Strader et al., 1988; Haughey et al., 1989; United Kingdom
Testicular Cancer Study Group (UK), 1994; Gallagher et al., 1995;
Davies et al., 1996; Moller et al., 1996; Prener et al., 1996; Petridou
et al., 1997; Sabroe and Olsen, 1998; Weir et al., 2000; Stang
et al., 2001; Bonner et al., 2002; Herrinton et al., 2003; Dieckmann
and Pichlmeier, 2004; Hardell et al., 2007; McGlynn et al., 2007;
Walschaerts et al., 2007; Dusek et al., 2008; Lacson et al., 2012)
for which midpoint TGCT diagnosis years ranged from 1960’s
through 1990+, revealed no evidence that CO became more com-
mon among TGCT-free men during this period (ptrend = 0.295,
data not shown).
Separate analyses of SEER 9 incidence data revealed that while
annual age-standardized incidence of non-seminoma/mixed GCT
increased over 28% (from 1.8 to 2.3 new diagnoses per 100,000)
from 1973–1978 to 1994–1998, the increase in seminoma was
far greater, 68% (from 2.2 to 3.7 per 100,000) during the same
interval (Figure S2).
DISCUSSION
Meta-analysis of data from case-control and cohort studies sug-
gests that young men with a history of CO experience approx-
imately 4-fold increased risk of TGCT. Estimates from TGCT
case-series whose frequency of CO was compared with separate
populations were regarded as unreliable; this practice may cause
severe bias (Rothman et al., 2008), which may account for the
far larger sRR and between-study variation estimated from these
reports.
Addressing more subtle differences in study design, we found
that sRR estimates from case-control and cohort studies were
notably modified by methods used to determine a man’s his-
tory of CO. The stronger association estimated in the single
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case-control study in which history of CO was determined from
medical record notes made at TGCT diagnosis may have arisen
from better recall of CO among cases than controls, since CO
was a recognized TGCT risk factor when these diagnoses were
made. Such recall bias may have contributed, also, to large effects
reported for case series, because history of COwas similarly deter-
mined in all of these studies. Undescended testes that descended
spontaneously in infancy would rarely be recorded in medical
records after the neonatal period, or recalled by study partic-
ipants or their mothers. We therefore anticipate that only the
single study in which COwas recorded at birth (Sabroe andOlsen,
1998) would have identified a high proportion of men with this
history. Weak CO-TGCT association reported in this study may
indicate that boys born with CO whose testes descend sponta-
neously in early months experience TGCT risk approaching that
of the general population. This possibility has implications for
both managing CO and understanding origins of TGCT, so we
hope that it will be explored further in retrospective cohorts for
which there are detailed neonatal records.
The apparent modification of sRR by features of CO and
TGCT may provide insight regarding TGCT etiology. Two gen-
eral explanations for the CO-TGCT association have long been
offered. The common cause hypothesis attributes the association
to one or more unidentified etiologic factors shared by CO and
TGCT, whereas the position hypothesis asserts that suprascro-
tal environment increases malignant potential of undescended
testes. Hussman suggested two testable predictions of the posi-
tion hypothesis (Husmann, 2005): (1) in unilateral CO, fully
descended contralateral testes should not experience elevated
TGCT risk, and (2) early orchiopexy should decrease TGCT risk.
Regarding the first, we estimated a lesser sRR for contralateral
testes [1.5(95% CI = 0.9–2.6)] than for ipsilateral testes [5.4(95%
CI = 3.7–7.8)], suggesting a deleterious effect of suprascrotal
position. Also consistent with positional effects, sRR among those
with bilateral non-descent [9.8(95% CI = 6.2–15.7)] was, within
statistical precision of the meta-analysis, indistinguishable from
twice sRR of those with unilateral non-descent [2×sRRipsilateral =
10.8(7.4–15.6)]. However, published data are insufficient (24
cases in 7 studies) to rule out a small increase in risk to con-
tralateral testes (e.g., 20%), as would be required to strictly affirm
Hussman’s first prediction. We note, however, that some true
increase in risk to contralateral testes would not necessarily rule
out the position hypothesis, because central responses to a sin-
gle testis in a suprascotal position could, in theory, contribute
to malignant potential of the contralateral testis. For example,
in rodent models of unilateral CO created surgically, degenera-
tive changes (Quinn, 1991; Zakaria et al., 1998) and altered gene
expression (Iizuka et al., 1996) were demonstrated in contralat-
eral, descended testes. A phenomenon observed in humans is
also consistent with this possibility: among patients with unilat-
eral TGCT who undergo biopsy of the contralateral testis, men
with a history of CO are more often found to have the presump-
tive TGCT precursor carcinoma in situ testis/intra-tubular germ
cell neoplasia than those without history of CO (Dieckmann and
Loy, 1996). Regarding Hussman’s second prediction, we observed
greater TGCT risk among those who experienced later resolution.
However, we cannot confidently conclude that deleterious effects
of suprascrotal position are responsible. An alternate explanation,
which we cannot rule out, is that men with earlier resolution of
CO experienced as a group inherently lower risk of TGCT. This
might occur, for example, if this group included a higher pro-
portion of boys destined to experience spontaneous descent if
therapeutic intervention had been delayed. Because elevated risk
was observed, regardless of age at orchiopexy, the clinical signifi-
cance of available data is that patients undergoing orchiopexy at
any age should be closelymonitored; thus alongwith their parents
or primary care givers and primary care physicians, they should
be made aware of the increased risk.
Unfortunately, published data could not distinguish between
risks experienced by men with histories of abdominal vs. inguinal
non-descent. These distinct phenotypes may provide a means of
determining relevance to human CO and TGCT of animal mod-
els of CO with high (Hsieh-Li et al., 1995; Rijli et al., 1995; Good
et al., 1997; Nef and Parada, 1999; Overbeek et al., 2001) or low
(Hutson, 1986; Lahoud et al., 2001) non-descent resulting from
disruption of specific genes. If found to be relevant to human
CO and TGCT, these models may become valuable tools in TGCT
research, which has long suffered from absence of animal models
of common forms of TGCT (Oosterhuis and Looijenga, 2005).
Therefore, documenting position of undescended testes before
orchiopexy may be useful for future research and in follow-up of
men with a history of CO, particularly in the era of electronic
medical records.
Modification by features of TGCT may suggest etiologic het-
erogeneity of these tumors.
Morrison (1976) apparently first suggested that CO is
more strongly associated with seminoma than non-seminoma,
although subsequent reports were inconsistent. Themeta-analysis
suggested greater RR for seminoma than for non-seminoma,
and an intermediate value for mixed GCT, by addressing a far
larger set of data than any single study and treating mixed GCT
as a distinct histologic type. Although mechanisms underlying
this pattern remain unknown, this finding suggests that tumors
of distinct histologic types may have separate etiologies and/or
result from events at different developmental stages. This possi-
bility accords with the far more dramatic decreases in the CO-
seminoma association observed over time. This trend, together
with the observation that incidence of seminoma has risen more
rapidly than that of non-seminoma/mixed GCT (Figure S2),
raises the intriguing possibility that increasing occurrence of
seminoma may involve increasing exposure to unidentified envi-
ronmental factors through processes unrelated to CO.
In conclusion, this meta-analysis provides a detailed quanti-
tative summary of available high-quality observational data on
the association between CO and TGCT, including observations
that can no longer be made due to trends toward younger age
at CO repair and increasing TGCT incidence. Results of subgroup
analyses indicate possible future directions in understanding both
stratification of TGCT risk among boys born with undescended
testes and TGCT etiology. Meta analyses addressing features of
CO suggest that while bilateral CO is associated with nearly twice
the TGCT risk as unilateral CO, data are inadequate to assess the
role of anatomic position of the undescended testis. Early repair
is associated with lower TGCT risk, but published data do not
provide a basis for recommending optimal time of repair or to
determine whether optimal repair can reduce risk to baseline.
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Therefore, all CO patients and their families should be counseled
to be aware of future risk. Additional data are needed to affirm
the possibility that TGCT risk is not elevated among boys whose
testes descend spontaneously after birth. Results of subgroup
analyses addressing features of TGCT suggest multiple pathways
to malignancy and indicate considerable heterogeneity in risk
of TGCT following CO. Both possibilities warrant mechanistic
examination using contemporary tools of molecular biology.
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